Delivery Order SPE2DB22D2007-SPE2DB25FJ4QP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $13,436.87 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565405204 - NURTEC ODT 75 MG TABLET 8S. This delivery order is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- The Defense Logistics Agency (DLA) awarded a $21,852.87 delivery order contract to AmerisourceBergen Drug Corporation for the supply of NURTEC ODT 75 MG tablets. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does...
- The Defense Logistics Agency awarded a delivery order valued at $3,089.51 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on August 27, 2025, with completion due by August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,971.64 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity 8). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 21, 2025, and represents a continuation of the contractor's pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $50,529.26 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $16,385.42 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S pharmaceuticals to support military treatment programs and facilities. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $18,445.91 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,769.77 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $4,346.12 contract is for the supply of NURTEC ODT 75 MG TABLET 8S to support military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4QPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,331.02 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure. This delivery order is executable through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company holds substantial contract authority under the DLA's Pharmaceutical Prime Vendor Global Program, which the agency is modernizing through a multi-award strategy involving multiple regional contractors. This specific delivery order represents one of numerous firm fixed-price transactions the vendor fulfills through the DLA supply chain, supporting the company's established role in delivering specialized medications and medical commodities across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/4/25 |